In 2016, a randomized trial from NYU found that a single dose of psilocybin delivered rapid improvements in anxiety and depression in cancer patients when combined with psychotherapy. A follow-up study found that 71–100% of participants reported that the improvement in depression and anxiety had lasted five years—with participants “rating it among the most personally meaningful experiences of their lives.” ACCESS STUDY
![](https://globalwellnessinstitute.org/wp-content/uploads/2021/05/mushroom.jpg)